Table 2.
Poisson segmented regression models of the impact of COVID-19 lockdown on HIV services at 65 clinics in KwaZulu-Natal, South Africa
Incidence rate ratio at lockdown | Incidence rate ratio at study end | Pre-lockdown trend* | Post-lockdown trend* | ||
---|---|---|---|---|---|
HIV testing† | |||||
Overall | 0·524 (0·446–0·615) | 0·827 (0·704–0·972) | 1·015 (1·009–1·022) | 1·183 (1·113–1·256) | |
Gender | |||||
Women | 0·563 (0·480–0·661) | 0·865 (0·741–1·010) | 1·013 (1·007–1·019) | 1·169 (1·100–1·247) | |
Men | 0·456 (0·387–0·537) | 0·761 (0·638–0·907) | 1·020 (1·013–1·028) | 1·210 (1·147–1·277) | |
District | |||||
Urban | 0·515 (0·436–0·610) | 0·827 (0·700–0·978) | 1·016 (1·010–1·023) | 1·190 (1·115–1·270) | |
Rural | 0·823 (0·681–0·994) | 0·785 (0·639–0·965) | 0·996 (0·985–1·006) | 0·980 (0·922–1·042) | |
ART initiation‡ | |||||
Overall | 0·538 (0·459–0·630) | 0·753 (0·637–0·890) | 0·996 (0·991–1·004) | 1·156 (1·085–1·230) | |
Gender | |||||
Women | 0·495 (0·417–0·588) | 0·801 (0·651–0·985) | 0·996 (0·987–1·004) | 1·225 (1·118–1·341) | |
Men | 0·616 (0·513–0·740) | 0·675 (0·571–0·797) | 1·000 (0·996–1·009) | 1·040 (0·957–1·132) | |
Age, years | |||||
0–14 | 0·370 (0·153–0·896) | 0·544 (0·270–1·096) | 0·996 (0·987–1·004) | 1·175 (0·640–2·164) | |
15–24 | 0·400 (0·334–0·479) | 0·772 (0·640–0·932) | 1·022 (1·013–1·031) | 1·363 (1·256–1·476) | |
25–49 | 0·577 (0·492–0·676) | 0·739 (0·624–0·876) | 0·991 (0·987–1·000) | 1·108 (1·040–1·180) | |
≥50 | 0·481 (0·399–0·579) | 0·796 (0·664–0·953) | 0·991 (0·983–1·000) | 1·230 (1·161–1·335) | |
District | |||||
Urban | 0·536 (0·458–0·628) | 0·750 (0·631–0·892) | 0·996 (0·991–1·004) | 1·156 (1·080–1·230) | |
Rural | 0·588 (0·365–0·947) | 0·863 (0·625–1·191) | 0·987 (0·983–0·996) | 1·166 (0·869–1·560) | |
ART collection visits‡ | |||||
Overall | 0·932 (0·794–1·093) | 0·859 (0·747–0·989) | 1·009 (1·000–1·013) | 0·974 (0·900–1·053) | |
Gender | |||||
Women | 0·916 (0·780–1·075) | 0·865 (0·753–0·994) | 1·009 (1·000–1·013) | 0·983 (0·908–1·062) | |
Men | 0·965 (0·823–1·131) | 0·847 (0·733–0·978) | 1·009 (1·004–1·013) | 0·953 (0·880–1·031) | |
Age, years | |||||
0–14 | 0·908 (0·790–1·043) | 0·780 (0·703–0·866) | 1·013 (1·009–1·017) | 0·949 (0·888–1·017) | |
15–24 | 0·875 (0·766–1·001) | 0·851 (0·753–0·960) | 1·026 (1·017–1·031) | 1·013 (0·957–1·071) | |
25–49 | 0·933 (0·796–1·094) | 0·865 (0·751–0·995) | 1·009 (1·000–1·013) | 0·974 (0·900–1·053) | |
≥50 | 0·946 (0·787–1·137) | 0·836 (0·710–0·984) | 1·004 (1·000–1·009) | 0·949 (0·861–1·049) | |
District | |||||
Urban | 0·926 (0·786–1·090) | 0·850 (0·736–0·982) | 1·009 (1·004–1·013) | 0·970 (0·896–1·053) | |
Rural | 1·065 (0·969–1·171) | 1·080 (0·985–1·185) | 0·996 (0·991–1·000) | 1·000 (0·957–1·044) | |
Missed ART collection visits‡ | |||||
Overall | 1·926 (1·585–2·341) | 0·682 (0·455–1·021) | 1·000 (0·996–1·004) | 0·569 (0·432–0·747) | |
Gender | |||||
Women | 2·045 (1·686–2·481) | 0·691 (0·454–1·052) | 0·996 (0·991–1·000) | 0·555 (0·419–0·734) | |
Men | 1·710 (1·399–2·090) | 0·664 (0·457–0·965) | 1·000 (0·996–1·004) | 0·601 (0·463–0·779) | |
Age, years | |||||
0–14 | 1·568 (1·325–1·856) | 0·555 (0·429–0·717) | 1·004 (1·000–1·009) | 0·572 (0·472–0·690) | |
15–24 | 1·682 (1·413–2·001) | 0·554 (0·374–0·820) | 1·022 (1·017–1·026) | 0·561 (0·430–0·727) | |
25–49 | 1·947 (1·594–2·378) | 0·685 (0·451–1·042) | 1·000 (0·996–1·000) | 0·566 (0·428–0·751) | |
≥50 | 2·030 (1·665–2·474) | 0·782 (0·552–1·109) | 0·987 (0·983–0·991) | 0·589 (0·463–0·751) | |
District | |||||
Urban | 1·991 (1·621–2·446) | 0·677 (0·433–1·057) | 1·000 (0·996–1·004) | 0·555 (0·412–0·751) | |
Rural | 1·274 (1·111–1·460) | 0·745 (0·636–0·872) | 1·004 (0·996–1·009) | 0·751 (0·674–0·834) |
Data are incidence rate ratio (95% CI) or trend (95% CI). ART=antiretroviral therapy.
Slope change per month
Autocorrelation addressed using Newey–West standard errors to calculate CI, with lag up to 2.
Autocorrelation addressed using Newey–West standard errors to calculate CI, with lag up to 3.